Paul J. Lockhart

11.9k citations

126 papers · 5.2k indexed · 2 hit papers · h-index 34

Molecular Biology top 5%
Nutrition and Dietetics top 0.5%
Cellular and Molecular Neuroscience top 1%
Neurology top 1%
Genetics top 2%

Co-authors: Matthew J. Farrer Julian F. B. Mercer James Camakaris Michael J. Petris J. F. B. Mercer Martin B. Delatycki Janetta G. Culvenor Paul A. Gleeson
Topics: Parkinson's Disease Mechanisms and Treatments (29 papers)Genetic Neurodegenerative Diseases (24 papers)RNA regulation and disease (15 papers)
Cited by: Nutrition and Dietetics Neurology Cellular and Molecular Neuroscience
Journals: Journal of Biological Chemistry Neuron Nature Genetics
Partner nations: Australia United States United Kingdom

In The Last Decade

Paul J. Lockhart

123 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Isolation of a partial candidate gene for Menkes disease by positional cloning

1993 545 citations Julian F. B. Mercer, Bryan Hall et al. Nature Genetics profile →
Ligand-regulated transport of the Menkes copper P-type ATPase efflux pump from the Golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking.

1996 525 citations Paul J. Lockhart et al. profile →

Peers

Countries citing papers authored by Paul J. Lockhart

Since Specialization

Citations

This map shows the geographic impact of Paul J. Lockhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Lockhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Lockhart more than expected).

Fields of papers citing papers by Paul J. Lockhart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. Lockhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Lockhart. The network helps show where Paul J. Lockhart may publish in the future.

Co-authorship network of co-authors of Paul J. Lockhart

This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Lockhart. A scholar is included among the top collaborators of Paul J. Lockhart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Lockhart. Paul J. Lockhart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ectopic HCN4 Provides a Target Biomarker for the Genetic Spectrum of mTORopathies 2024 ·Neurology Genetics ·Matthew Coleman,(unknown),Sarah Stephenson,(unknown),(unknown),Catriona McLean,Katherine B. Howell,Richard J. Leventer,Christopher A. Reid,Paul J. Lockhart	2
2	Brain volumes in genetic syndromes associated with mTOR dysregulation: a systematic review and meta-analysis 2024 ·Molecular Psychiatry ·Jonathan M. Payne,(unknown),(unknown),Kiymet Bozaoglu,(unknown),Paul J. Lockhart,(unknown),Silvia Velasco,Gareth Ball,Kathryn N. North,Darren R. Hocking	0
3	The clinical, imaging, pathological and genetic landscape of bottom-of-sulcus dysplasia 2023 ·Brain ·(unknown),Aaron E. L. Warren,Peter Francis,Simone Mandelstam,(unknown),Matthew Coleman,Sarah Stephenson,Sarah Barton,Colleen D’Arcy,Paul J. Lockhart,Richard J. Leventer,A. Simon Harvey	11
4	Expanding the clinical and radiological phenotypes of leukoencephalopathy due to biallelic HMBS mutations 2021 ·American Journal of Medical Genetics Part A ·Chloe Stutterd,Alexa Kidd,Chris Florkowski,Edward Janus,(unknown),Anthony Raizis,Teddy Y. Wu,John S. Archer,Richard J. Leventer,David J. Amor,Vesna Lukić,Melanie Bahlo,Paul Gow,Paul J. Lockhart,Marjo S. van der Knaap,Martin B. Delatycki	2
5	Prevalence of RFC1 -mediated spinocerebellar ataxia in a North American ataxia cohort 2020 ·Neurology Genetics ·(unknown),Darice Y. Wong,(unknown),Claudio M. de Gusmão,(unknown),May Sanyoura,(unknown),Paul J. Lockhart,Sharon Hassin‐Baer,Vikram Khurana,Christopher M. Gómez,Susan Perlman,Soma Das,Brent L. Fogel	32
6	Distribution of Parkinson’s disease associated RAB39B in mouse brain tissue 2020 ·Molecular Brain ·Yujing Gao,Gabrielle R. Wilson,Sarah Stephenson,Mustapha Oulad‐Abdelghani,Nicolas Charlet‐Berguerand,Kiymet Bozaoglu,Catriona McLean,Paul Q. Thomas,David I. Finkelstein,Paul J. Lockhart	7
7	Prevalence of RFC1-Mediated Spinocerebellar Ataxia in a North American Ataxia Cohort 2020 ·Annals of Neurology ·(unknown),Darice Y. Wong,(unknown),Claudio M. de Gusmão,(unknown),May Sanyoura,(unknown),Paul J. Lockhart,Sharon Hassin‐Baer,Vikram Khurana,Christopher M. Gómez,Susan Perlman,Soma Das,Brent L. Fogel	3
8	Generation of four iPSC lines from Neurofibromatosis Type 1 patients 2020 ·Stem Cell Research ·Kiymet Bozaoglu,(unknown),(unknown),Kathryn N. North,Jonathan M. Payne,Paul J. Lockhart	2
9	Second‐hit DEPDC5 mutation is limited to dysmorphic neurons in cortical dysplasia type IIA 2019 ·Annals of Clinical and Translational Neurology ·(unknown),Sarah Stephenson,Katherine B. Howell,Kate Pope,Greta Gillies,Alison Wray,Wirginia Maixner,Simone Mandelstam,Samuel F. Berkovic,Ingrid E. Scheffer,Duncan MacGregor,A. Simon Harvey,Paul J. Lockhart,Richard J. Leventer	55
10	Genetic Analysis of Patients Who Experienced Awareness with Recall while under General Anesthesia 2019 ·Anesthesiology ·Jamie Sleigh,Kate Leslie,Andrew Davidson,David J. Amor,Peter Diakumis,Vesna Lukić,Paul J. Lockhart,Melanie Bahlo	5
11	Familial early onset Parkinson's disease caused by a homozygous frameshift variant in PARK7: Clinical features and literature update 2019 ·Parkinsonism & Related Disorders ·Sarah Stephenson,Ruth Djaldetti,Haloom Rafehi,Gabrielle R. Wilson,Greta Gillies,Melanie Bahlo,Paul J. Lockhart	7
12	An Open Label Clinical Pilot Study of Resveratrol as a Treatment for Friedreich Ataxia (S43.006) 2013 ·Neurology ·Eppie M. Yiu,Geneieve Tai,Roger E. Peverill,Katherine J. Lee,Kevin D. Croft,Trevor A. Mori,Sarah Stephenson,Paul J. Lockhart,Joseph P. Sarsero,Andrew Churchyard,Marguerite V. Evans‐Galea,Monique M. Ryan,Louise A. Corben,Martin Delatycki	2
13	ironXS: high-school screening for hereditary haemochromatosis is acceptable and feasible 2012 ·European Journal of Human Genetics ·Martin B. Delatycki,(unknown),Veronica Collins,(unknown),(unknown),Katrina J. Allen,Lyle C. Gurrin,MaryAnne Aitken,M. Kaye Trembath,Lyndal Bond,Gabrielle R. Wilson,Sarah Stephenson,Ivan Macciocca,Chriselle Hickerton,Paul J. Lockhart,Sylvia A. Metcalfe	8
14	Mutant torsinA interacts with tyrosine hydroxylase in cultured cells 2009 ·Neuroscience ·Casey O’Farrell,Karen L. M. Martin,M. Hutton,Martin B. Delatycki,Mark Cookson,Paul J. Lockhart	15
15	Multiplication of the α-Synuclein Gene Is Not a Common Disease Mechanism in Lewy Body Disease 2004 ·Journal of Molecular Neuroscience ·Paul J. Lockhart,Jennifer M. Kachergus,Sarah Lincoln,Mary Hulihan,Gina Bisceglio,Natalie Thomas,Dennis W. Dickson,Matthew J. Farrer	8
16	It's a double knock‐out! The quaking mouse is a spontaneous deletion of parkin and parkin co‐regulated gene (PACRG) 2004 ·Movement Disorders ·Paul J. Lockhart,Casey O’Farrell,Matthew J. Farrer	48
17	Lack of mutations in DJ‐1 in a cohort of Taiwanese ethnic Chinese with early‐onset parkinsonism 2004 ·Movement Disorders ·Paul J. Lockhart,Rebecca Bounds,Mary Hulihan,Jennifer M. Kachergus,Sarah Lincoln,Chin‐Hsien Lin,Ruey‐Meei Wu,Matthew J. Farrer	19
18	Accurate Determination of Ataxin-2 Polyglutamine Expansion in Patients with Intermediate-Range Repeats 2002 ·Genetic Testing ·Jennifer Hussey,Paul J. Lockhart,William Seltzer,Zbigniew K. Wszołek,Haydeh Payami,Melissa Hanson,Katrina Gwinn,Matthew J. Farrer	14
19	Parkin Protects against the Toxicity Associated with Mutant α-Synuclein 2002 ·Neuron ·Leonard Petrucelli,Casey O’Farrell,Paul J. Lockhart,Melisa J. Baptista,Kathryn Kehoe,(unknown),Peter S. Choi,Benjamin Wolozin,Matthew J. Farrer,John Hardy,Mark Cookson	457
20	Isolation of a partial candidate gene for Menkes disease by positional cloningbreakdown → 1993 ·Nature Genetics ·Julian F. B. Mercer,(unknown),Bryan Hall,Jennifer A. Paynter,Catherine R. Begy,Settara C. Chandrasekharappa,Paul J. Lockhart,Andrew Grimes,Mrinal Bhave,David Siemieniak,Thomas W. Glover	545

About Paul J. Lockhart

Paul J. Lockhart is a scholar working on Cellular and Molecular Neuroscience, Neurology and Neurology, having authored 126 papers that have together received 5.2k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (29 papers), Genetic Neurodegenerative Diseases (24 papers) and RNA regulation and disease (15 papers). The work is most often cited by research in Nutrition and Dietetics (1.5k citations), Neurology (1.2k citations) and Cellular and Molecular Neuroscience (1.2k citations). Paul J. Lockhart has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Matthew J. Farrer, Julian F. B. Mercer, James Camakaris, Michael J. Petris, J. F. B. Mercer, Martin B. Delatycki, Janetta G. Culvenor, Paul A. Gleeson, Thomas W. Glover and Jennifer A. Paynter. Their work appears in journals such as Journal of Biological Chemistry, Neuron and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact